Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • sdlmark
    Junior Member
    • Mar 2015
    • 2

    #1

    Majority of reads counted in stranded=reverse using HTSeq?

    Hello,

    I'm new to working with RNAseq data and have a question about counting reads with HTSeq.

    I have stranded data that was mapped using the default parameters in STAR. I am counting the reads using HTSeq with the parameters:
    --type=exon
    --mode=intersection-nonempty
    --idattr=Parent
    --format=bam
    When I use the --stranded=yes option, fewer than 10% of reads are counted; the majority have "no feature." But when I use the --stranded=reverse option, over 80% of the reads are counted. Similarly, when I use the --stranded=no option, over 80% of the reads are counted.

    I'm just wondering what could explain this pattern. Is this a typical outcome? Should I be concerned? I think that as a newbie I must be missing some key information about the stranded RNAseq protocol. Which, in this case, was the Illumina TruSeq Stranded protocol.

    I'm pretty stumped so any insight into this matter would be greatly appreciated!

    Thanks,

    SM
  • Michael.Ante
    Senior Member
    • Oct 2011
    • 127

    #2
    Hi SM,

    IMHO, you should not be worried. I would suggest, you get a bit more informed about your data (e.g. here https://www.biostars.org/p/64250/, the HTSeq-count manual ).
    HTSeq-count is counting the reads, which align to the given exons. If you use the stranded option "yes", it checks whether the reads are in the same orientation as the transcript. Illumina's TruSeq Stranded protocol produces libraries, which are in reverse orientation to the transcripts' one.
    The more overlapping genes you have, the stronger becomes the influence of the stranded-option in HTSeq-count.
    The resulting number of usable reads depends on the pre-processing, the reads' mapping-quality, the annotation (e.g. RefSeq vs. Ensembl annotation), ....
    Additionally, I'd recommend having a look at some genes, using e.g. the IGV browser and collect some statistics with RSeQC.

    Comment

    • sdlmark
      Junior Member
      • Mar 2015
      • 2

      #3
      Thanks for the tips and info! I understand it better now.

      SM

      Originally posted by Michael.Ante View Post
      Hi SM,

      IMHO, you should not be worried. I would suggest, you get a bit more informed about your data (e.g. here https://www.biostars.org/p/64250/, the HTSeq-count manual ).
      HTSeq-count is counting the reads, which align to the given exons. If you use the stranded option "yes", it checks whether the reads are in the same orientation as the transcript. Illumina's TruSeq Stranded protocol produces libraries, which are in reverse orientation to the transcripts' one.
      The more overlapping genes you have, the stronger becomes the influence of the stranded-option in HTSeq-count.
      The resulting number of usable reads depends on the pre-processing, the reads' mapping-quality, the annotation (e.g. RefSeq vs. Ensembl annotation), ....
      Additionally, I'd recommend having a look at some genes, using e.g. the IGV browser and collect some statistics with RSeQC.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...